SIRT1 and non-small cell lung carcinoma: Moreover, we found that overexpression of SIRT1 significantly decreased NNMT shRNA-induced gefitinib sensitivity in EGFR-TKI-resistant NSCLC cells, suggesting that SIRT1 is involved in NNMT-mediated gefitinib resistance in NSCLC cells.